Growth factor (member of the transforming growth factor-beta (TGF-β) superfamily), Hormone (forms heterodimeric hormones, e.g. inhibin), Ligand (for serine/threonine kinase receptors)
01
Overview
Inhibin subunit beta A is a protein encoded by the INHBA gene and is a member of the transforming growth factor-beta (TGF-β) superfamily[1][2][4][5]. It forms the βA subunit of activin and inhibin dimers, which play foundational roles in regulating secretion of follicle-stimulating hormone (FSH) from the pituitary gland, modulating cell proliferation and differentiation, and controlling developmental and physiological processes in multiple tissues[1][2][5]. Dysregulation of INHBA expression, especially in the form of activin A, is implicated in promoting tumor progression, invasion, and poor clinical outcomes in several cancers, making it a candidate therapeutic target and disease biomarker[2][3][4][5]. The protein also influences immune responses, reproductive physiology, and tissue development, and signals primarily through canonical TGF-β receptor/SMAD pathways along with non-canonical signaling pathways[5].
Other names
Inhibin beta A chainActivin beta-A chainErythroid differentiation protein (EDF)FSH-releasing protein (FRP)Inhibin, beta-1Erythroid differentiation factorFollicle-stimulating hormone-releasing proteinInhibin beta A subunitInhibin, beta A (activin A, activin AB alpha polypeptide)
02
Mechanism of action
Inhibition of activin A/INHBA signaling—typically through ligand neutralization or receptor antagonism—to decrease cancer cell proliferation, invasion, and to modulate immune response[2][5]. Follistatin and other binding proteins inhibit activin signaling by direct sequestration[2].
03
Biological functions
Regulation of follicle-stimulating hormone secretionRegulation of gonadal stromal cell proliferationCell growth and differentiationSignal transduction (TGF-β, SMAD, MAPK, ERK1/2, JNK pathways)Modulation of immune responsesControl of embryonic and tissue developmentModulation of stem cell maintenanceInsulin secretionBone growthPromotion of tumor progression and metastasis (when overexpressed)Regulation of cell proliferation and apoptosis
04
Disease associations
Cancer (solid tumors including gastric, lung, ovarian, esophageal, prostate, head and neck squamous cell carcinoma)Cancer cachexiaEndometrial cancerOther contexts such as developmental and reproductive disorders
05
Safety considerations
Targeting TGF-β superfamily members, including INHBA/activin A, may have on-target effects on reproductive physiology, hematopoiesis, immune function, and tissue homeostasis[2][5].Inhibition could lead to deleterious effects on normal tissue development, fertility, and metabolic functions.
06
Interacting drugs
There are no FDA-approved drugs specifically targeting INHBA, but research compounds and biologics are being developed to inhibit or modulate activin A signaling, including follistatin and other activin antagonists[2][5].
07
Biomarkers
INHBA expression as a prognostic marker in multiple cancers (e.g., gastric cancer, lung adenocarcinoma, ovarian cancer, head and neck squamous cell carcinoma)[2][3][5].Serum inhibin A/activin A levels as biomarkers for granulosa-cell tumors and possibly for disease monitoring in some cancers[1][5].
Beyond the preview
Go deeper on Inhibin subunit beta A (INHBA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inhibin subunit beta A (INHBA).